ArticleWorld journal of surgical oncology2024

Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.

Fei Pei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.